CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Over-The-Counter Monograph Drug User Fee Program (OMUFA)

RegulatoryNeutral
AI Analysis

Summary

The FDA is considering a user fee program (OMUFA) for over-the-counter monograph drugs to supplement congressional appropriations as a potential funding mechanism.

Importance:2/10
Sentiment:
0.00
OTCmonographuser fee programregulatory
Related Companies

Read the original article

Published by FDA Drugs (New Approvals & NDA) on July 29, 2026 1:18 PM

Read Original